Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis

British Journal of Dermatology, Supplement

Volumn 135, Issue 49, 1996, Pages 32-36

  Weinstein, G D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; RETINOIC ACID; RETINOID; TAZAROTENE;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERYTHEMA; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION;

EID: 0029827538     PISSN: 0366077X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb15664.x     Document Type: Conference Paper

References (6)

1. Frost PF, Weinstein GD. Topical administration of Vitamin A acid for ichthyosifiorm dermatoses and psoriasis. J Am A led Assoc 1969: 206: 1863-968.
2. Fredriksson T. Antipsoriatic activity of retinoic acid (vitamin A acid). Dermatologica 1971; 142: 133-6.
3. MacDonald A. McMinn RMH. Fry L. Effect of retinoic acid in psoriasis. II. Long-term study. Br J Dennatol 1972; 87: 256-60.
4. Orfanos CE. Schmidt HU', Mahrlc G et al Rctinoic acid in psoriasis: ils value for topical therapy with and without corticosteroids. Clinical, histological. and electron microscopical studies on fortyfour hospitalized patients with extensive psoriasis. Br JDermatol 1973:88: 167-82.
5. Günther S. The therapeutic value of retinoic acid in chronic, acute, guttäte, and erythrodermic psoriasis: clinical observations on twenty-five patients. Rr J Dermatol 1973; 89: 515-17.
6. Bischoff R, DC Jong EMGJ, Rulo HFC et al Topical application of 13-ris-retinoic acid in the treatment of chronic plaque psoriasis. Clin Exp Dermatol 1992: 17: 9-12.